CRISPR/Cas as a Potential Diagnosis Technique for COVID-19.
Mahintaj Dara(Shiraz University), Mahdieh Talebzadeh(Shiraz University of Medical Sciences)
PubMed Central
July 23, 2020
Cited by 26
Related Papers
Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial
|Lipids in Health and Disease|2024|69
A comparative in vitro and in vivo study on bone tissue engineering potential of the collagen/nano-hydroxyapatite scaffolds loaded with ginger extract and curcumin
|Materials Today Communications|2022|40
Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology
|Human Gene|2024|28
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease
|International Journal of Biological Macromolecules|2023|24